← Back to Clinical Trials
Recruiting NCT06525285

NCT06525285 MCAF and EMD With and Without CTG Wall Technique for the Treatment of Class III and IV Gingival recessions-a Randomized Control Trial

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06525285
Status Recruiting
Phase
Sponsor Krishnadevaraya College of Dental Sciences & Hospital
Condition Gingival Recession
Study Type INTERVENTIONAL
Enrollment 24 participants
Start Date 2024-07-19
Primary Completion 2025-01-12

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 60 Years
Study Type INTERVENTIONAL
Interventions
Connective tissue graft wall technique

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 24 participants in total. It began in 2024-07-19 with a primary completion date of 2025-01-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Research is to compare and evaluate the clinical outcomes of the Connective tissue graft wall technique with modified coronally advanced flap to improve root coverage and clinical attachment levels in Miller's class III and IV gingival recession.

Eligibility Criteria

Inclusion Criteria: * Participants aged 18-60 years * Systemically healthy individuals * Participants with Miller's Class III and IV or Cairo's RT3 gingival recession in maxillary and mandibular anteriors. * Participants with Nordland and Tarnow's papillary recession of either I, II or III. * Presence of interdental PPD, CAL and recession * Radiographic evidence of interdental bone loss * No prior experience of root coverage procedures * Able to achieve good oral hygiene and control gingivitis in the whole of the dentition (FMPS \< 25% and FMBS \< 25%). Exclusion Criteria: * Grade III mobile teeth * Pathologically migrated teeth * Endodontically treated teeth * Open contacts * Pregnancy and lactating women * Participants with systemic conditions * Untreated periodontitis * Persistence of uncorrected gingival trauma from tooth brushing * Self-reported current smoking * Presence of medical contraindications to elective surgery

Contact & Investigator

Central Contact

Prabhuji MLV, MDS

✉ prabhujimlv@gmail.com

📞 9448057407

Frequently Asked Questions

Who can join the NCT06525285 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Gingival Recession. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06525285 currently recruiting?

Yes, NCT06525285 is actively recruiting participants. Contact the research team at prabhujimlv@gmail.com for enrollment information.

Where is the NCT06525285 trial being conducted?

This trial is being conducted at Bengaluru, India.

Who is sponsoring the NCT06525285 clinical trial?

NCT06525285 is sponsored by Krishnadevaraya College of Dental Sciences & Hospital. The trial plans to enroll 24 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology